InMode to Participate in Upcoming Investor Conferences
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode (Nasdaq: INMD) will participate in three investor conferences in November 2025: the UBS Global Healthcare Conference (in-person one-on-ones, Palm Beach Gardens, FL) on Monday, November 10; the Jefferies Global Healthcare Conference (in-person fireside chat and one-on-ones, London, U.K.) with a fireside chat at 4:00 pm GMT on Tuesday, November 18 and a live webcast available; and the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (in-person one-on-ones, New York, NY) on Thursday, November 20. Presenters include CEO Moshe Mizrahy and CFO Yair Malca.
Details
News Market Reaction – INMD
On Oct 30, the day this news came out, INMD closed 1.41% below the previous close.
Data tracked by StockTitan Argus for the Oct 30 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM,
UBS Global Healthcare Conference
Presenter: Yair Malca, Chief Financial Officer
Format: In-person one-on-one meetings
Location:
When: Monday, November 10
Jefferies Global Healthcare Conference
Presenter: Moshe Mizrahy, Chief Executive Officer
Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst, and one-on-one meetings
Location:
When: Tuesday, November 18, Fireside Chat at 4:00 pm GMT
A live webcast of the presentation can be accessed here.
Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Presenter: Yair Malca, Chief Financial Officer
Format: In-person one-on-one meetings
Location:
When: Thursday, November 20
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-upcoming-investor-conferences-302598806.html
SOURCE InMode Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.